90261241 - MUNJOVI

Information

• Trademark
• 90261241

• Source

• Serial Number

  90261241

• Registration Number

  6625339

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 17, 2020
  3 years ago

• Registration Date

  January 25, 2022
  2 years ago

• Transaction Date

  February 01, 2024
  3 months ago

• Status Date

  January 25, 2022
  2 years ago

• Published for Opposition Date

  November 09, 2021
  2 years ago

• Location Date

  January 25, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  GANDARA, KEYLA MARIA

• Attorney Docket Number

  114353.00139

  Attorney Name

  Michael J. Leonard

  Law Office Assigned Location Code

  N30

• Owners

  • MorphoSys AG

Case File Statements

• GS0051: Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
• GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Case File Event Statements

• 1/31/2024 - 3 months ago

  18 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 1/25/2022 - 2 years ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/9/2021 - 2 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/9/2021 - 2 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/20/2021 - 2 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/5/2021 - 2 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/28/2021 - 2 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/28/2021 - 2 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/20/2021 - 2 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/26/2021 - 3 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/26/2021 - 3 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/26/2021 - 3 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/17/2021 - 3 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 3/9/2021 - 3 years ago

  5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX

• 3/1/2021 - 3 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 12/4/2020 - 3 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/27/2020 - 3 years ago

  2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 10/21/2020 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP